SNCA and Parkinson disease: At present, several proposed PD biomarkers have failed to correlate with diagnosis and/or progression, including perturbed dopamine metabolites, decreased levels of alpha-synuclein in the cerebrospinal fluid and elevated levels of oligomeric alpha-synuclein in the plasma [11], gait-cycle irregularities [12], and isotope tracing to the SNpc [13].